NDLI: Identification of neuraminidase inhibitors by structure-based screening: promising new leads for influenza

Content Provider	Springer Nature Link
Author	Bhakat, Soumendranath Shaikh, Faraz Yadav, Siddharth Rawal, Rakesh M.
Copyright Year	2013
Abstract	Human influenza commonly known as seasonal flu which is caused by a RNA virus has been emerging as a major viral infection over the years. Virus neuraminidase inhibitors and M2 protein inhibitors are the agents which have been used to treat this viral infection. Among these two, viral neuraminidases named oseltamivir and zanamivir are most widely used as antiviral agents to treat influenza. But the recent emergence of resistance strains in the treatment with both zanamivir and oseltamivir creates a big problem to treat this viral infection effectively. In this study, we have designed 68 new human influenza virus neuraminidase inhibitors and reported them as new potential antiviral agents against the complex structure of influenza virus neuraminidase and sialic acid using various in silico tools and molecular docking analysis taking zanamivir as prototype.
Starting Page	2803
Ending Page	2809
Page Count	7
File Format	PDF
ISSN	10542523
Journal	Medicinal Chemistry Research
Volume Number	23
Issue Number	6
e-ISSN	15548120
Language	English
Publisher	Springer US
Publisher Date	2013-11-12
Publisher Place	New York
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Neuraminidase inhibitor Zanamivir Influenza Structure–activity relationship (SAR) Molecular docking Pharmacology/Toxicology Biochemistry Cell Biology
Content Type	Text
Resource Type	Article
Subject	Organic Chemistry Pharmacology, Toxicology and Pharmaceutics

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

MD studies on neuraminidase for probing binding pose of its inhibitors

Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor

Use of structure-based virtual screening in the investigation of novel human sialidase inhibitors

Virtual screening-based identification of lead molecules as selective TACE inhibitors

Elaborate ligand-based modeling reveals new human neutrophil elastase inhibitors

A combined approach based on 3D pharmacophore and docking for identification of new aurora A kinase inhibitors

Quantitative structure activity relationship and docking studies of imidazole-based derivatives as P-glycoprotein inhibitors

Docking and quantitative structure–activity relationship studies for imidazo[1,2-a]pyrazines as inhibitors of checkpoint kinase-1

Virtual screening based on pharmacophoric features of known calpain inhibitors to identify potent inhibitors of calpain

Identification of neuraminidase inhibitors by structure-based screening: promising new leads for influenza

Similar Documents

MD studies on neuraminidase for probing binding pose of its inhibitors

Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor

Use of structure-based virtual screening in the investigation of novel human sialidase inhibitors

Virtual screening-based identification of lead molecules as selective TACE inhibitors

Elaborate ligand-based modeling reveals new human neutrophil elastase inhibitors

A combined approach based on 3D pharmacophore and docking for identification of new aurora A kinase inhibitors

Quantitative structure activity relationship and docking studies of imidazole-based derivatives as P-glycoprotein inhibitors

Docking and quantitative structure–activity relationship studies for imidazo[1,2-a]pyrazines as inhibitors of checkpoint kinase-1

Virtual screening based on pharmacophoric features of known calpain inhibitors to identify potent inhibitors of calpain

Identification of neuraminidase inhibitors by structure-based screening: promising new leads for influenza